Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $12,416 - $13,569
-86 Reduced 1.74%
4,848 $708,000
Q1 2024

Aug 14, 2024

SELL
$155.22 - $162.74 $46,721 - $48,984
-301 Reduced 5.75%
4,934 $780,000
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $73,528 - $80,234
505 Added 10.68%
5,235 $820,000
Q3 2023

Oct 31, 2023

SELL
$155.75 - $174.48 $3,270 - $3,664
-21 Reduced 0.44%
4,730 $736,000
Q4 2022

Jan 30, 2023

SELL
$160.2 - $179.79 $3,204 - $3,595
-20 Reduced 0.42%
4,751 $839,000
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $1,739 - $1,975
11 Added 0.23%
4,771 $846,000
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $315,602 - $350,172
2,024 Added 73.98%
4,760 $814,000
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $16,150 - $17,947
-100 Reduced 3.53%
2,736 $442,000
Q1 2021

May 06, 2021

SELL
$153.07 - $170.48 $2,908 - $3,239
-19 Reduced 0.67%
2,836 $466,000
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $5,347 - $6,137
-39 Reduced 1.35%
2,855 $449,000
Q4 2019

Jan 30, 2020

SELL
$127.5 - $146.44 $54,187 - $62,237
-425 Reduced 12.81%
2,894 $422,000
Q3 2018

Nov 06, 2018

BUY
$121.58 - $142.88 $403,524 - $474,218
3,319 New
3,319 $459,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Blankinship & Foster, LLC Portfolio

Follow Blankinship & Foster, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blankinship & Foster, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blankinship & Foster, LLC with notifications on news.